Slow to Report

Sponsors aren't reporting clinical trial data like they are supposed to, according to an analysis performed by Duke University researchers.

Part of the Food and Drug Administration Amendments Act requires sponsors to register their non-phase I clinical trials of drugs, medical devices, or biologics, and report basic summary results at ClinicalTrials.gov within a year of the completion of data collection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.